Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma

被引：0
作者：
A F Hottinger
A B Aissa
V Espeli
D Squiban
N Dunkel
M I Vargas
T Hundsberger
N Mach
K Schaller
D C Weber
A Bodmer
P-Y Dietrich
机构：
[1] Clinical Research Unit of the Foundation Dr Henri Dubois Ferriére Dinu Lipatti & Centre of Oncology,Department of Clinical Neurosciences & Oncology
[2] Geneva University Hospitals and University of Geneva,Department of Neuroradiology
[3] CHUV University Hospital and University of Lausanne,Department of Neurology and hematology/oncology
[4] Geneva University Hospitals and University of Geneva,Department of Radio
[5] Cantonal Hospital St Gallen,oncology
[6] Department of Neurosurgery Geneva University Hospitals and University of Geneva,undefined
[7] Geneva University Hospitals and University of Geneva,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
high-grade glioma; temozolomide; sorafenib; tyrosine kinase inhibitor; radiation therapy; pharmacokinetic study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2655 / 2661
页数：6
相关论文
共 383 条
[1]  
Agarwal S(2011)The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain J Pharmacol Exp Ther 336 223-328
[2]  
Sane R(2009)Phase II trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases Clin Cancer Res 15 7711-1518
[3]  
Ohlfest JR(2008)Selected combination therapy with sorafenib: a review of clinical data and perspectives in advanced solid tumors Oncologist 13 845-undefined
[4]  
Elmquist WF(2002)Mutations of the BRAF gene in human cancer Nature 417 949-undefined
[5]  
Amaravadi RK(2012)A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and rRecurrent high-grade gliomas Int J Radiat Oncol Biol Phys 85 321-undefined
[6]  
Schuchter LM(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-undefined
[7]  
McDermott DF(2010)Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme Cancer 116 3663-undefined
[8]  
Kramer A(2012)Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma Clin Adv Hematol Oncol 10 240-undefined
[9]  
Giles L(1992)Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops Cancer Res 52 3213-undefined
[10]  
Gramlich K(2007)Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme Neuro Oncol 9 291-undefined
12345678910